Randall Moreadith Age X Therapeutics, Inc. (AGE) insider trading activity

AGE Quotes by TradingView

Randall Moreadith is Chief Scientific Officer of AgeX Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Dec 23, 2025, when has been sold 4,100 shares (Common Stock) at a price of $2.6 per share, resulting in proceeds of $10,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Randall Moreadith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
SELL
Open market or private sale
$10,660 $2.6 p/Share
4,100 Reduced 100.0%
0 Common Stock
Dec 23 2025
BUY
Exercise of conversion of derivative security
$246 $0.06 p/Share
4,100 Added 50.0%
4,100 Common Stock
Dec 22 2025
SELL
Open market or private sale
$15,146 $2.67 p/Share
5,673 Reduced 100.0%
0 Common Stock
Dec 22 2025
BUY
Exercise of conversion of derivative security
$340 $0.06 p/Share
5,673 Added 50.0%
5,673 Common Stock
Dec 16 2025
SELL
Open market or private sale
$9,551 $2.96 p/Share
3,227 Reduced 100.0%
0 Common Stock
Dec 16 2025
BUY
Exercise of conversion of derivative security
$193 $0.06 p/Share
3,227 Added 50.0%
3,227 Common Stock
Dec 12 2025
SELL
Open market or private sale
$5,542 $3.26 p/Share
1,700 Reduced 100.0%
0 Common Stock
Dec 12 2025
BUY
Exercise of conversion of derivative security
$102 $0.06 p/Share
1,700 Added 50.0%
1,700 Common Stock
Dec 11 2025
SELL
Open market or private sale
$11,518 $3.24 p/Share
3,555 Reduced 100.0%
0 Common Stock
Dec 11 2025
BUY
Exercise of conversion of derivative security
$213 $0.06 p/Share
3,555 Added 50.0%
3,555 Common Stock
Dec 10 2025
SELL
Open market or private sale
$2,160 $3.35 p/Share
645 Reduced 100.0%
0 Common Stock
Dec 10 2025
BUY
Grant, award, or other acquisition
$38 $0.06 p/Share
645 Added 50.0%
645 Common Stock
Dec 09 2025
SELL
Open market or private sale
$1,986 $3.31 p/Share
600 Reduced 100.0%
0 Common Stock
Dec 09 2025
BUY
Exercise of conversion of derivative security
$36 $0.06 p/Share
600 Added 50.0%
600 Common Stock
Dec 03 2025
SELL
Open market or private sale
$17,600 $3.52 p/Share
5,000 Reduced 100.0%
0 Common Stock
Dec 03 2025
BUY
Exercise of conversion of derivative security
$300 $0.06 p/Share
5,000 Added 50.0%
5,000 Common Stock
Dec 02 2025
SELL
Open market or private sale
$5,865 $3.91 p/Share
1,500 Reduced 100.0%
0 Common Stock
Dec 02 2025
BUY
Exercise of conversion of derivative security
$90 $0.06 p/Share
1,500 Added 50.0%
1,500 Common Stock
Nov 25 2025
SELL
Open market or private sale
$23,263 $3.9 p/Share
5,965 Reduced 50.0%
5,965 Common Stock
Nov 25 2025
BUY
Exercise of conversion of derivative security
$357 $0.06 p/Share
5,965 Added 33.33%
11,930 Common Stock
Nov 24 2025
SELL
Open market or private sale
$2,107 $3.94 p/Share
535 Reduced 100.0%
0 Common Stock
Nov 24 2025
BUY
Exercise of conversion of derivative security
$32 $0.06 p/Share
535 Added 50.0%
535 Common Stock
Nov 18 2025
SELL
Open market or private sale
$24,375 $3.75 p/Share
6,500 Reduced 100.0%
0 Common Stock
Nov 18 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Nov 10 2025
SELL
Open market or private sale
$26,649 $4.1 p/Share
6,500 Reduced 100.0%
0 Common Stock
RM

Randall Moreadith

Chief Scientific Officer
Huntsville, AL

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGE